Ono Pharmaceutical Co Ltd 2018 Integrated Report
The report highlights FY2017 consolidated revenue of ¥261,836 million, 3,480 consolidated employees, a 10.1% reduction in energy-derived CO2 emissions to 24,000 tons versus FY2005, and participation in the UN Global Compact. It also describes a more than 23% CO2 reduction target for FY2020.
Company: Ono Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2018
Type: Integrated Report
Pages: 120
Back to company
Ono Pharmaceutical Co Ltd
Corporate Report
The report highlights FY2017 consolidated revenue of ¥261,836 million, 3,480 consolidated employees, a 10.1% reduction in energy-derived CO2 emissions to 24,000 tons versus FY2005, and participation in the UN Global Compact. It also describes a more than 23% CO2 reduction target for FY2020.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Apr 1, 2017 - Mar 31, 2018
Fiscal Year
2017
Published
Aug 1, 2018
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees